ARCpoint Inc. (TSXV: ARC), a healthcare technology company operating the MAPL clinical lab software platform, has announced the resignation of board member David Keys, effective September 14, 2026. Keys cited a need to devote more time to director obligations with other issuers. The departure leaves ARCpoint's board with three remaining members, and the company states it is actively working to identify and appoint additional qualified directors. The announcement comes while the company's shares remain suspended on the TSX Venture Exchange.

Key Points

  • ARCpoint Inc. (TSXV: ARC) — healthcare technology company based in Greenville, South Carolina
  • Director David Keys resigned from the Board of Directors effective September 14, 2026, to focus on other director obligations
  • The board now comprises three members: Zelong ("Roger") He, John Constantine, and Adam Ho
  • Investors may be watching whether ARCpoint can identify and appoint qualified directors while its shares remain suspended

David Keys Departs ARCpoint Board After Citing Competing Director Commitments

ARCpoint announced on September 16, 2026, that David Keys had stepped down from its Board of Directors, with the resignation taking effect two days earlier on September 14, 2026. According to the release, Keys chose to resign in order to devote more time to his director obligations with other issuers. The company expressed gratitude for his service and contributions and extended best wishes for his future endeavours. The announcement did not disclose the length of Keys' tenure on the board or any further details regarding his other commitments.

ARCpoint's Remaining Three-Member Board and Director Recruitment Efforts

Following the departure, ARCpoint's Board of Directors consists of three members: Zelong ("Roger") He, John Constantine, and Adam Ho, who also serves as the company's Chief Financial Officer. The company states it is taking steps to identify and appoint additional qualified directors, though the release provides no specific timeline or candidate details. The company's forward-looking disclosure cautions that there is no assurance additional directors will be identified or appointed within any particular timeframe, or at all, given regulatory and candidate-availability considerations.

MAPL Platform Business and Suspended Trading Status Add Complexity

ARCpoint describes itself as a healthcare technology company that owns and develops MAPL, a multi-tenant software platform serving clinical laboratories, collection sites, and healthcare service providers across the United States for lab ordering, scheduling, and results delivery. The company's Class A Subordinate Voting Shares trade on the TSX Venture Exchange under the symbol ARC but are noted as currently suspended. The immediate share price impact was not clear from available public information, given the ongoing trading suspension.